Pulmonary complications of Bcr-Abl tyrosine kinase inhibitors

Jason Weatherald, Louise Bondeelle, Marie-Camille Chaumais, Christophe Guignabert, Laurent Savale, Xavier Jaïs, Olivier Sitbon, Philippe Rousselot, Marc Humbert, Anne Bergeron, David Montani

Source: Eur Respir J, 56 (4) 2000279; 10.1183/13993003.00279-2020
Journal Issue: October
Disease area: Pulmonary vascular diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Jason Weatherald, Louise Bondeelle, Marie-Camille Chaumais, Christophe Guignabert, Laurent Savale, Xavier Jaïs, Olivier Sitbon, Philippe Rousselot, Marc Humbert, Anne Bergeron, David Montani. Pulmonary complications of Bcr-Abl tyrosine kinase inhibitors. Eur Respir J, 56 (4) 2000279; 10.1183/13993003.00279-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: